載入...
An Emerging Treatment Alternative for Anemia in Chronic Kidney Disease Patients: A Review of Daprodustat
This article reviews an emerging therapeutic agent, which is currently in phase III development for the treatment of anemia secondary to chronic kidney disease, covering promising phase II results, drug characteristics, and the current phase III trials, which, if approved, may significantly impact t...
Na minha lista:
| 發表在: | Adv Ther |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer Healthcare
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5778168/ https://ncbi.nlm.nih.gov/pubmed/29285707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-017-0655-z |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|